These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 24477283)

  • 21. Bioactivities of Halometabolites from Marine Actinobacteria.
    Kasanah N; Triyanto T
    Biomolecules; 2019 Jun; 9(6):. PubMed ID: 31212626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro cytotoxic effects of benzalkonium chloride on adenovirus.
    Lazzaro DR; Abulawi K; Hajee ME
    Eye Contact Lens; 2009 Nov; 35(6):329-32. PubMed ID: 19826252
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Marine Actinomycetes-Derived Secondary Metabolites Overcome TRAIL-Resistance via the Intrinsic Pathway through Downregulation of Survivin and XIAP.
    Elmallah MIY; Cogo S; Constantinescu AA; Elifio-Esposito S; Abdelfattah MS; Micheau O
    Cells; 2020 Jul; 9(8):. PubMed ID: 32708048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Drug development against human adenoviruses and its advancement by Syrian hamster models.
    Wold WSM; Tollefson AE; Ying B; Spencer JF; Toth K
    FEMS Microbiol Rev; 2019 Jul; 43(4):380-388. PubMed ID: 30916746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure-based design and optimization of potent inhibitors of the adenoviral protease.
    Grosche P; Sirockin F; Mac Sweeney A; Ramage P; Erbel P; Melkko S; Bernardi A; Hughes N; Ellis D; Combrink KD; Jarousse N; Altmann E
    Bioorg Med Chem Lett; 2015 Feb; 25(3):438-43. PubMed ID: 25571794
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification of Inhibitors and Drug Targets for Human Adenovirus Infections.
    Liu M; Jiang L; Cao W; Wu J; Chen X
    Viruses; 2022 May; 14(5):. PubMed ID: 35632701
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and Comparative Study of Anti-Adenoviral Activity of 6-Azacytidine and Its Analogues.
    Alexeeva I; Nosach L; Palchykovska L; Usenko L; Povnitsa O
    Nucleosides Nucleotides Nucleic Acids; 2015; 34(8):565-78. PubMed ID: 26167665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biodiversity of Secondary Metabolites Compounds Isolated from Phylum Actinobacteria and Its Therapeutic Applications.
    Al-Shaibani MM; Radin Mohamed RMS; Sidik NM; Enshasy HAE; Al-Gheethi A; Noman E; Al-Mekhlafi NA; Zin NM
    Molecules; 2021 Jul; 26(15):. PubMed ID: 34361657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [New medical treatment for viral conjunctivitis].
    Uchio E
    Nippon Ganka Gakkai Zasshi; 2005 Dec; 109(12):962-84; discussion 985. PubMed ID: 16408491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marine actinomycetes: an ongoing source of novel bioactive metabolites.
    Subramani R; Aalbersberg W
    Microbiol Res; 2012 Dec; 167(10):571-80. PubMed ID: 22796410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic basis of vidarabine on adenovirus-induced haemorrhagic cystitis.
    Kurosaki K; Miwa N; Yoshida Y; Kurokawa M; Kurimoto M; Endo S; Shiraki K
    Antivir Chem Chemother; 2004 Sep; 15(5):281-5. PubMed ID: 15535050
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiviral prophylaxis with twice daily topical cidofovir protects against challenge in the adenovirus type 5/New Zealand rabbit ocular model.
    Romanowski EG; Yates KA; Gordon YJ
    Antiviral Res; 2001 Dec; 52(3):275-80. PubMed ID: 11675144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Marine bacterial sources of bioactive compounds.
    Jaiganesh R; Sampath Kumar NS
    Adv Food Nutr Res; 2012; 65():389-408. PubMed ID: 22361201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel Alkaloids from Marine Actinobacteria: Discovery and Characterization.
    De Rop AS; Rombaut J; Willems T; De Graeve M; Vanhaecke L; Hulpiau P; De Maeseneire SL; De Mol ML; Soetaert WK
    Mar Drugs; 2021 Dec; 20(1):. PubMed ID: 35049861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Evaluation of antiviral agents for adenovirus using the MTT method in vitro].
    Kaneko H; Fujiwara T; Mori S; Shigeta S
    Nippon Ganka Gakkai Zasshi; 2000 Nov; 104(11):786-91. PubMed ID: 11530368
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel marine actinobacteria from emerald Andaman & Nicobar Islands: a prospective source for industrial and pharmaceutical byproducts.
    Meena B; Rajan LA; Vinithkumar NV; Kirubagaran R
    BMC Microbiol; 2013 Jun; 13():145. PubMed ID: 23800234
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro and in vivo activities of antibiotic PM181104.
    Mahajan G; Thomas B; Parab R; Patel ZE; Kuldharan S; Yemparala V; Mishra PD; Ranadive P; D'Souza L; Pari K; Sivaramkrishnan H
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5315-9. PubMed ID: 23939903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Culturable rare Actinomycetes: diversity, isolation and marine natural product discovery.
    Subramani R; Aalbersberg W
    Appl Microbiol Biotechnol; 2013 Nov; 97(21):9291-321. PubMed ID: 24057404
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adenovirus infection in the immunocompromised host.
    Tebruegge M; Curtis N
    Adv Exp Med Biol; 2010; 659():153-74. PubMed ID: 20204763
    [No Abstract]   [Full Text] [Related]  

  • 40. [Adenovirus infection in immunocompromised patients].
    Rynans S; Dzieciątkowski T; Młynarczyk G
    Postepy Hig Med Dosw (Online); 2013 Sep; 67():964-72. PubMed ID: 24088540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.